ArticleMMWR. Morbidity and mortality weekly report2018
Global Routine Vaccination Coverage - 2017.
Article in MMWR. Morbidity and mortality weekly report, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04042246 (Knowledge on Vaccination Schedule and Full Immunization, and Its Effect on Vaccine Take-up in Jada Local Government Area in Adamawa State, Northeastern Nigeria), which is not on this map. Cited by 72 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Knowledge on Vaccination Schedule and Full Immunization, and Its Effect on Vaccine Take-up in Jada Local Government Area in Adamawa State, Northeastern Nigeria
Who cites it
72 citing papers in PubMed, 4 syntheses or guidelines pooled it.
- Incomplete immunization and its determinants among children in Africa: Systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2023Pooled it
- Vaccination dropout among children in Sub-Saharan Africa: Systematic review and meta-analysis.Human vaccines & immunotherapeutics · 2022Pooled it
- Vaccine equity in low and middle income countries: a systematic review and meta-analysis.International journal for equity in health · 2022Pooled it
- Full immunization coverage and associated factors among children age 12-23 months in Ethiopia: systematic review and meta-analysis of observational studies.Human vaccines & immunotherapeutics · 2021Pooled it
- Effect of tailored information of vaccination schedule on vaccine uptake in northern Nigeria.Human vaccines & immunotherapeutics · 2021Trial
- Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study.BMJ open · 2020Trial
- Epidemiological burden of pertussis in children in Asia: a review of 1990-2021 data and future projections.Translational pediatrics · 2026Article
- Zeolitic Imidazolate Frameworks Allows for the Thermal Stabilization of Live Viral Vaccine in the Absence of Lyophilization.ACS omega · 2025Article
- Standardized vaccination practices for preterm infants: Egyptian experts' consensus.BMC infectious diseases · 2025Article
- Article
- Propensity score matching analysis of the effect of four or more antenatal care visits on basic childhood immunization in Ethiopia.Scientific reports · 2025Article
- Uptake of second dose measles containing vaccine and associated factors among children aged 24-35 months in central Ethiopia: a community based cross-sectional study.BMC public health · 2025Article
- Delayed completion of pneumococcal conjugate vaccination among children 4-48 months in rural Uganda: a socio-demographic inquiry.BMC pediatrics · 2025Article
- Individual and community level maternal factors for zero-dose children in Ethiopia using mini-EDHS 2019: a mixed effects model.BMJ open · 2025Article
- Article
- Zero-dose children and the extended immunisation cascade: Understanding the path to full immunisation with six childhood vaccines in 43 countries.Journal of global health · 2024Article
- Article
- Exploring the reasons for defaulting from childhood immunization: a qualitative study in Pakistan.BMC public health · 2024Article
- Timely Vaccination and Its Associated Factors Among Parents With Children Aged From 0 to 23 Months in Wolaita Zone Public Hospitals, Southern Ethiopia, 2024: A Facility-Based Cross-Sectional Study.Global pediatric health · 2024Article
- Article
12 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Endorsed by the World Health Assembly in 2012, the Global Vaccine Action Plan 2011-2020 (GVAP) (1) calls on all countries to reach ≥90% national coverage with all vaccines in the country's national immunization schedule by 2020. This report updates previous reports (2,3) and presents global, regional, and national vaccination coverage estimates and trends as of 2017. It also describes the number of infants surviving to age 1 year (surviving infants) who did not receive the third dose of diphtheria and tetanus toxoids and pertussis-containing vaccine (DTP3), a key indicator of immunization program performance (4,5), with a focus on the countries with the highest number of children who did not receive DTP3 in 2017. Based on the World Health Organization (WHO) and United Nations Children's Fund (UNICEF) estimates, global DTP3 coverage increased from 79% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). In 2017, among the 19.9 million children who did not receive DTP3 in the first year of life, 62% (12.4 million) lived in 10 countries. From 2007 to 2017, the number of children who had not received DTP3 decreased in five of these 10 countries and remained stable or increased in the other five. Similar to DTP3 coverage, global coverage with the first measles-containing vaccine dose (MCV1) increased from 80% in 2007 to 84% in 2010, and has remained stable from 2010 to 2017 (84% to 85%). Coverage with the third dose of polio vaccine (Pol3) has remained stable at 84%-85% since 2010. From 2007 to 2017, estimated global coverage with the second MCV dose (MCV2) increased from 33% to 67%, as did coverage with the completed series of rotavirus (2% to 28%), pneumococcal conjugate (PCV) (4% to 44%), rubella (26% to 52%), Haemophilus influenzae type b (Hib) (25% to 72%) and hepatitis B (HepB) (birth dose: 24% to 43%; 3-dose series: 63% to 84%) vaccines. Targeted, context-specific strategies are needed to reach and sustain high vaccination coverage, particularly in countries with the highest number of unvaccinated children.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.